CFO Corleen Roche resigns effective Aug 5; Robert Lapetina named interim principal financial officer

CG Oncology, Inc.

CFO Corleen Roche resigns effective August 5, 2025.
Robert Lapetina, VP FP&A since May 2024, appointed interim principal financial and accounting officer.
Lapetina previously VP Finance and Controller at Immunome, Inc. and roles at Chubb, Teleflex, Pfizer.

item 5.02

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.